Jove
Visualize
Contact Us

Related Experiment Videos

Regulatory issues for computerized electrocardiographic devices.

Neal I Muni1, Charles Ho, Elias Mallis

  • 1Department of Health and Human Services, Center for Devices and Radiological Health, US Food and Drug Administration, Rockville, MD, USA. neal.muni@fda.hhs.gov

Journal of Electrocardiology
|November 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2024
Same author

Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells.

Biomolecules·2023
Same author

Association between headache and suicidality: An analysis of universal suicide screening data at a large urban county hospital.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2022
Same author

Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein.

Viruses·2021
Same author

Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.

International journal of molecular sciences·2020
Same author

Genes Associated with Calcium Signaling are Involved in Alcohol-Induced Breast Cancer Growth.

Alcoholism, clinical and experimental research·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Manufacturers of computerized electrocardiogram (ECG) devices must distinguish between "tool" and "clinical" claims for FDA approval. Both claim types undergo rigorous regulatory scrutiny by the FDA Center for Devices and Radiological Health (CDRH).

Area of Science:

  • Medical Devices
  • Regulatory Science
  • Cardiology

Background:

  • Computerized electrocardiogram (ECG) devices are subject to FDA regulation in the U.S.
  • The FDA's Center for Devices and Radiological Health (CDRH) oversees these devices.
  • Understanding regulatory pathways is crucial for manufacturers.

Purpose of the Study:

  • To elucidate the FDA regulatory review process for computerized ECG devices.
  • To highlight the critical distinction between "tool" claims and "clinical" claims.
  • To guide manufacturers on navigating regulatory pathways for device approval.

Main Methods:

  • Analysis of FDA regulatory guidelines for medical devices.
  • Examination of intended use claims for computerized ECG devices.

Related Experiment Videos

  • Distinction between device measurement capabilities and health hazard implications.

    • Main Results:

    • "Tool" claims focus on accurate measurement of ECG parameters (e.g., T-wave alternans).
    • "Clinical" claims relate to health hazards associated with parameters (e.g., sudden death risk).
    • Both claim types receive equivalent regulatory scrutiny from the FDA.

    Conclusions:

    • Manufacturers must clearly differentiate "tool" and "clinical" claims for ECG devices.
    • Regulatory pathways and approval considerations differ based on claim type.
    • Thorough understanding of FDA requirements ensures successful device commercialization.